News Kees Kramers appointed Professor of Medication safety

7 December 2017

The appointment went into effect on 1 November 2017. Kramers' teaching and research focuses on medication safety in the hospital setting. Medication errors are one of the biggest risks for hospitalised patients. It is estimated that half of these errors could be prevented through targeted education and supervision of prescribers. The chair therefore has a strong educational orientation.

Kramers is the first Professor of Medication Safety to be appointed in Nijmegen. In the past there has been a long time close collaboration between physicians and pharmacists in Nijmegen. This collaboration is a prerequisite for medication safety.

CV
Kees Kramers (Dirksland, 1962) received his doctorate in Medicine from the University of Leiden in 1986. From 1989 until 1996 he was trained as an internist and from 1996 to 1998 as an internist-clinical pharmacologist, both at Radboud university medical center. In 1995 he obtained his PhD at Radboud University on research into antibodies that play a role in renal failure in the autoimmune disease systemic lupus erythematodes.

Training programmes in medication safety
Since 1989 Kramers has worked at Radboud university medical center on the staff of the Department of Pharmacology-Toxicology, and from 1998 he has also been on the staff of the Department of Internal Medicine, where he is responsible for patient care and teaching and research. Since 2010 he has been seconded to the Clinical Pharmacy Department at Canisius Willhelmina Hospital (CWZ) in Nijmegen. 
In these roles he developed training programmes in medication safety for beginning physician assistants at Radboud university medical center and CWZ. He also chairs the Dutch Society for Clinical Pharmacology & Biopharmacy.

Expertise Centre
His recent achievements include the founding of the Nijmeegs Expertisecentrum voor Complexe Farmacotherapie (‘Nijmegen Expertise Centre for Complex Pharmacotherapy’), a regional partnership between hospital pharmacies, regional general practitioners and public pharmacists, and the development of a compulsory national pharmacotherapy exam for future physicians.

Related news items


Christine Mohrmann stipendium for Karlien Mul

14 December 2018

The goal of the stipendium is to enable junior female scientists to perform research abroad and to encourage them to pursue a scientific career in academia.

read more

Call for nominations RIHS Awards 2017 & 2018

14 December 2018

RIHS researchers are invited to propose candidates for the RIHS PhD Award, the Societal Impact Award, the Science Award and the Supervisor of the year Award. Deadline for nominations is 14 January 2019.

read more

Bart Kiemeney among most cited researchers

13 December 2018

Bart Kiemeney made it to this year’s list of highly cited researchers. Researchers in this list are selected for their exceptional research performance and are regarded to have had a major impact on fellow scientists.

read more

Metal surgical implants can activate drugs

13 December 2018

Marja Bulte-ter Meer and Leo Schultze Kool discovered that the iron in metal surgical implants can activate drugs such as antibiotics, thus enabling targeted therapy.

read more

Annual CaRe days 8 & 9 May 2019

13 December 2018

The CaRe days provides an inspiring program for all RIHS researchers. Save the date!

read more

Five RIMLS researchers in top 1 percent by citations

13 December 2018

Bas Dutilh, Leo Joosten, Jos van der Meer, Mihai Netea and Henk Stunnenberg made it to this year’s list of highly cited researchers. Researchers in this list are selected for their exceptional research performance and are regarded to have had a major impact on fellow scientists.

read more
  • Go to